This study focuses on developing a targeted approach by evaluating the efficacy of small peptides derived from pigment epithelium-derived factor (PEDF), known to restrict common cell death pathways associated with retinal diseases. The gene discussed is PNPLA2; the disease is Abnormal retinal morphology.